COMPANY PROFILE

Nuvig Therapeutics

Advancing innovative and transformational therapies that are designed to induce natural mechanisms to restore immune homeostasis, rebalance immune function

Redwood City, United StatesFounded 2021Biotech & Life Sciences

Valuation $500M–1B Last recorded · 2024

Revenue <$1M Latest reported FY

Headcount <100 Current team size

Total funding $100–500M Disclosed equity funding

Unlock exact values

About Nuvig Therapeutics

Nuvig Therapeutics is a cutting-edge research and clinical development company dedicated to creating innovative therapies for patients suffering from inflammatory and autoimmune diseases. Unlike traditional treatments that suppress the immune system, Nuvig focuses on restoring the body's natural immune balance. This approach aims to modulate immune function without the side effects commonly associated with immune suppression.

Nuvig Therapeutics serves patients with chronic inflammatory and autoimmune conditions, a market that is both significant and growing due to the increasing prevalence of these diseases. The company operates within the biopharmaceutical sector, which involves the development and commercialization of drugs based on biological molecules.

The business model of Nuvig Therapeutics revolves around scientific research and clinical trials. They invest heavily in understanding the underlying mechanisms of immune homeostasis—how the immune system maintains balance—and translate these insights into therapeutic products. Their revenue is primarily generated through the development and eventual commercialization of these therapies. This includes licensing their technologies to larger pharmaceutical companies, securing funding through grants, and potentially entering into joint ventures or partnerships.

Nuvig Therapeutics is committed to expanding its product pipeline to address various autoimmune conditions, thereby broadening its market reach. The company also places a strong emphasis on data privacy and compliance with regulations like the California Online Privacy Protection Act, ensuring that patient and client information is handled with the utmost care.

In summary, Nuvig Therapeutics is a forward-thinking biopharmaceutical company focused on developing novel therapies for autoimmune and inflammatory diseases by leveraging natural immune mechanisms. Their innovative approach, combined with a robust research and development framework, positions them well in a competitive market.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2021
Headquarters: Redwood City, United States
Employees: 23
Open positions: None listed
Dealroom signal: 67.2/100
Industry: Health
Sub-industry: BioTechnology, Health Platform
Sector: Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
Business model: SaaS
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

3 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES BOther financing	Dec 2024	$161M	$644M	Novo Holdings · B Capital · Leaps by Bayer · Platanus Ventures	↗
SERIES AOther financing	May 2022	$47M	$188M	Bristol-Myers Squibb · Digitalis Ventures · Mission BioCapital · Novo Holdings	↗

Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Year	Revenue	Growth
2026
2025
2024
2023
2022		—

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Nuvig Therapeutics website traffic

Latest recorded traffic for Nuvig Therapeutics is 2.3K monthly website visits, up 283.3% over the last three months. Nuvig Therapeutics's team declined 14.8% over the past year.

Latest monthly visits2.3K 3-month web change+283.3% 1-year team growth-14.8%

Monthly website visitsOct 2022–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
TATagomicsMultiomic platform for disease biomarker discovery and diagnostics	Cambridge, United Kingdom	Operational	25	$12M	$35M
RTReading TechnologyAn RandD company that uses imaging, data, AI diagnosis, and treatment technology for heart and brain diseases	Shenzhen, China	Operational
MAManaAn AI based drug delivery startup, creating a platform for Lipid Nanoparticle (LNP) development for oligonucleotide therapies including mRNA-based therapeutics, vaccines and gene therapy	Tel Aviv-Yafo, Israel	Operational
PHPhenomicshealthAn Artificial Intelligence-Powered Patient-Focused Precision Medicine company	Plymouth, United States	Operational
ATAthos therapeuticsPioneering the Development of Artificial Intelligence-based Precision Therapeutics for Chronic Inflammatory Diseases	Torrance, United States	Operational
SBSpear BioOffers opportunities for better detections with less invasive biospecimen collection	Woburn, United States	Operational
OXOXcanAI-powered liquid biopsy tests for early cancer detection	Oxford, United Kingdom	Operational
CLCleerlyA digital healthcare company transforming the way clinicians approach the treatment of heart disease	New York City, United States	Operational